NAD+ metabolism and kidney risk in intensive care
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether changes in NAD+ (a natural molecule in your cells) affect kidney health during intensive care. It aims to predict and prevent acute kidney injury in patients at high risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are admitted to intensive care for a serious condition like shock, sepsis, cardiac arrest, or emergency surgery
- Your kidneys are working normally when you are admitted
- You have health insurance (social security)
- You agree to participate and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests whether adding NAD can improve kidney health in people with diabetes-related kidney disease. It is designed for people with certain urine lab results showing kidney stress, while keeping blood sugar and safety limits within range.
This Phase 2 trial studies whether adding NAD+ can reduce heart muscle injury around scheduled heart surgery. It may help protect the heart (and possibly kidneys) in people considered higher risk for complications.
This trial tests ways to protect the kidneys in intensive-care patients who have moderate or severe acute kidney injury. If you are on a ventilator or medications to support blood pressure, this study may offer extra kidney care to help prevent further damage.
This study tests a urine test that may help detect kidney injury early in ICU patients. Early detection could lead to quicker treatment and better outcomes.
This study looks at how the kidneys work in both healthy people and those with reduced kidney function. Researchers want to understand kidney health better to help people in the future.
This trial tests whether a daily supplement called nicotinamide riboside (a form of vitamin B3) can help people with moderate chronic kidney disease. It aims to see if it can slow down kidney function decline and improve overall health.
Hear when a new NAD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.